Active BE 0791.839.803Private limited company

DALE Pharma

Grote Plaats(E) 50 ·7850 Enghien, Belgium· 3 yrs active

Sector: Retail trade (47120)

Conclusion Checked

The computed 12-month bankruptcy probability of DALE Pharma is 3.8% (moderate). The 2023 annual accounts show equity of €606k and a net result of €716. Its solvency ranks better than 52% of 796 sector peers (fiscal year 2023). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 1 annual account.

Key figures

Equity	€606k
Net result	€716
Staff (FTE)	17.6
Better than sector	52%

Snowflake analysis 5 axes · computed by Checked

47 / 100

Mixed profile: strong on stability, weaker on profitability.

Health 58

Profitability 13

Solvency 37

Growth 50

Stability 79

Bankruptcy probability (12 mo) Checked model v1 · free

3.8% Moderate

0%0,5%1,5%4%10%≥25%

Young company +Higher-failure-rate sector +Multiple establishment units +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based

0 / 100

Low risk

Trust signals 3 signals

More than 3 years active

Founded in 2022, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.

Administratively compliant

No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags 0 events

No administrative flags

Health barometer FY 2023 · computed

58 / 100 Fair

050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →

Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Financial overview1 NBB filings

Annual accounts filed on 15-08-2024 with the NBB · fiscal year 2023 · volledig

Sector comparison

Fiscal year 2023 · NACE 47, Retail trade · compared within the same schema type (full schema)

Metric	This company	Sector median	Position in the sector
Solvency	19.6%	17.8%	better than 52% of 796 sector peers
Net result	€716	€12k	better than 36% of 792 sector peers
Equity	€606k	€80k	better than 84% of 797 sector peers
Gross operating margin	€1.30M	€163k	better than 95% of 717 sector peers
Staff costs	€1.20M	€189k	higher than 91% of 625 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Highlight YoY changes (±10%)

Fiscal year	2023
Revenue	€3.28M
EBITDA	€95k
Net profit	€716
Cash flow	€51k
Staff costs	€1.20M
Income taxes	-
Dividends	-
Total assets	€3.08M
Equity	€606k
Debt	€2.48M
of which ≤ 1y	€1.75M
of which > 1y	€721k
Working capital	€995k
Employees (FTE)	17.6

Ratios (computed)

	2023
Current ratio	1.57
Quick ratio	0.82
Working capital ratio	32.2%
Solvency	19.6%
Debt / equity	4.09
Long-term debt ratio	1.19
Interest coverage	2.17
Gross margin	2.8%
Net margin	0.0%
ROA	0.0%
ROE	0.1%
EBITDA margin	2.9%
Days sales outstanding	151d
Days payable outstanding	133d
Inventory turnover	2.45
Days inventory (DSI)	149d

Balance-sheet composition 2023

Assets

Fixed assets €338k · 11.0% Current assets €2.75M · 89.0%

Equity & liabilities

Equity €606k · 19.7% Debt €2.48M · 80.4%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2023
Balance sheet, Assets
TOTAL ASSETS	20/58	€3.08M
Fixed assets	21/28	€338k
Formation expenses	20	€0
Intangible fixed assets	21	€192k
Tangible fixed assets	22/27	€146k
Financial fixed assets	28	€363
Current assets	29/58	€2.75M
Stocks & contracts in progress	3	€1.30M
Amounts receivable within one year	40/41	€1.41M
Investments	50/53	€0
Cash & bank	54/58	€34k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€3.08M
Equity	10/15	€606k
Contributions / capital	10/11	€605k
Accumulated profits (losses)	14	€716
Amounts payable	17/49	€2.48M
Amounts payable after one year	17	€721k
Amounts payable within one year	42/48	€1.75M
Trade debts payable within one year	44	€1.16M
Income statement
Turnover	70	€3.28M
Gross operating margin	9900	€1.30M
Operating result	9901	€44k
Financial income	75	€0
Financial charges	65	€44k
Result before taxes	9903	€716
Net result for the period	9904	€716
Result to be appropriated	9905	€716

Ratios computed by Checked.

Legal Structure

NACE primary	Retail trade(47120)
Legal form	Private limited company(610)
Incorporation	04-10-2022
Status	Active
Postal code	7850

Establishment units 2 locations

DALE PHARMA SRL

Grote Plaats(E) 50, 7850 EnghienApotheek

since 20222.337.233.707

DALE Pharma Auvelais

Avenue de la Libération(AUV) 63, 5060 SambrevilleApotheek

since 20222.338.412.949

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 2 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
55010D0046/00H000	Wallonia	239 m²	1 · 118 m²	-
92007F0104/00H002	Wallonia	229 m²	1 · 67 m²	13.8 m · 4 fl.

Methodology

via registered seat: 1 · via establishment units: 1

2 of 2 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Updates 5 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2024

12-09-2024

State Gazette act Registered-office change

15-08-2024

NBB filing Annual accounts filed

fiscal year 2023 · volledig

2023

01-08-2023

State Gazette act Capital & shares

Peter VAN MELKEBEKE

14-03-2023

State Gazette act Registered-office change

22-02-2023

State Gazette act Director changes

Belgisch Staatsblad, acts 4 acts

Capital history · 1

01-08-2023

Capital change

Address history · 2

12-09-2024

Registered-office move

14-03-2023

Registered-office move

All acts · 4 updated 1 year ago

2024

12-09-2024 Registered office moved from Chapelle-lez-Herlalmont to Enghien Registered-office change

Rue Joseph Francq 1 boîte 4-7160 Chapelle-lez-Herlalmont - Belgique → THE MUG ENGHIEN - Grand-Place 50 -7850 Enghien

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "THE MUG ENGHIEN - Grand-Place 50 -7850 Enghien",
        "city": "Enghien",
        "region": "waals_gewest",
        "street": "Grand-Place",
        "country": "BE",
        "postcode": "7850",
        "box_number": null,
        "street_number": "50",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Rue Joseph Francq 1 bo\u00EEte 4-7160 Chapelle-lez-Herlalmont - Belgique",
        "city": "Chapelle-lez-Herlalmont",
        "region": "waals_gewest",
        "street": "Rue Joseph Francq",
        "country": "BE",
        "postcode": "7160",
        "box_number": "4",
        "street_number": "1",
        "locality_suffix": null
      },
      "effective_date": "2024-07-01",
      "evidence_quote": "L\u0027assembl\u00E9e accepte \u00E0 l\u0027unanimit\u00E9 le transfert du si\u00E8ge social vers l\u0027adresse THE MUG ENGHIEN - Grand-Place 50 -7850 Enghien, en date du 01/07/2024.",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": null,
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-09-12",
    "filing_date": "2024-09-03",
    "act_kind_objet": "Transfert de si\u00E8ge"
  },
  "decision": {
    "body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
    "date": "2024-06-20",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0791.839.803",
    "name_full": "DALE Pharma",
    "legal_form": "SRL",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Didier P\u00EAtre",
    "org_rep_person_name": null,
    "person_role_at_subject": "Administrateur"
  },
  "co_filed_documents": [
    "Mod DOC 19.01"
  ]
}

2023

01-08-2023 Capital increase of €300,750 to €300,750 Capital & shares·Peter VAN MELKEBEKE

€0 → €300.750

Notary: Peter VAN MELKEBEKE · BruxellesFirm: BERQUIN NOTAIRES

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 300750.0,
      "delta_eur": 300750.0,
      "before_eur": 0.0,
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": null,
        "share_form": "nominal",
        "share_class": null,
        "n_new_shares": 250,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 1203.0
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 300750.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-08-01",
    "filing_date": "2023-07-28",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-07-25",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": true,
    "firm_kbo": null,
    "firm_name": null,
    "ibr_number": null,
    "mission_type": null,
    "individual_name": null
  },
  "subject_company": {
    "kbo": "0791.839.803",
    "name_full": "DALE Pharma",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "procuration",
    "texte coordonn\u00E9 des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

14-03-2023 Registered office moved from Bruxelles to Piéton Registered-office change

Boulevard de l'Empereur 10-1000 Bruxelles - Belgique → rue Joseph Francq 1 boite 4 à 7160 Piéton

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "combined",
      "new_address": {
        "raw": "rue Joseph Francq 1 boite 4 \u00E0 7160 Pi\u00E9ton",
        "city": "Pi\u00E9ton",
        "region": "waals_gewest",
        "street": "rue Joseph Francq",
        "country": "BE",
        "postcode": "7160",
        "box_number": "4",
        "street_number": null,
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Boulevard de l\u0027Empereur 10-1000 Bruxelles - Belgique",
        "city": "Bruxelles",
        "region": "brussels_hoofdstedelijk_gewest",
        "street": "Boulevard de l\u0027Empereur",
        "country": "BE",
        "postcode": "1000",
        "box_number": null,
        "street_number": "10",
        "locality_suffix": null
      },
      "effective_date": "2022-12-01",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale propose de modifier le si\u00E8ge de la soci\u00E9t\u00E9 situ\u00E9 actuellement sis boulevard de l\u0027empereur 10 \u00E0 1000 Bruxelles vers le si\u00E8ge d\u0027exploitation situ\u00E9e sis rue Joseph Francq 1 boite 4 \u00E0 7160 Pi\u00E9ton.",
      "region_changed": true,
      "is_statute_change": true,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": true,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": "2023-03-06",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "algemene_vergadering",
    "date": null,
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0791.839.803",
    "name_full": "DALE Pharma",
    "legal_form": "SRL"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "DIDIER P\u00CATRE",
    "org_rep_person_name": null,
    "person_role_at_subject": "Administrateur"
  },
  "co_filed_documents": [
    "Copie \u00E0 publier aux annexes au Moniteur belge apr\u00E8s d\u00E9p\u00F4t de l\u0027acte au greffe"
  ]
}

22-02-2023 1 director appointed, 2 resigning Director changes

Emilie Dewerpe, Bestuurder
Aurélie Wattiez, Bestuurder
Liouba Muzzin, Bestuurder

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Aur\u00E9lie Wattiez",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Liouba Muzzin",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Emilie Dewerpe",
        "address": "rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Emilie Dewerpe domicili\u00E9e rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re est propos\u00E9e comme administrateur",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Aur\u00E9lie Wattiez",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Liouba Muzzin",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Emilie Dewerpe",
        "address": "rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Emilie Dewerpe domicili\u00E9e rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re est propos\u00E9e comme administrateur",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-02-22",
    "filing_date": null,
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2023-02-13",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2023-02-13",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0791.839.803",
    "name_full": "DALE Pharma",
    "legal_form": "SRL"
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

Credit advice verdict per customer and amount

AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon

AI-generated from Checked data; indicative, not legal or investment advice.

Company registry (CBE) Crossroads Bank

Activities

Overige niet-gespecialiseerde detailhandel47120Detailhandel via postorderbedrijven of via internet47910Apotheken47730Detailhandel in farmaceutische producten47730Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels47740Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen47741Detailhandel in cosmetica en toiletartikelen in gespecialiseerde winkels47750Detailhandel in cosmetica en toiletartikelen47750

Primary activity highlighted.

Names & trade names

Legal nameFR

DALE Pharma

Registered office

Grote Plaats(E) 50

7850 Enghien, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.

Similar companies Same NACE

LEGERSTOCK TEUNISSEN BE 0453.873.688 · Hamont-Achel

SOLDERIE JOS BE 0464.144.010 · Rochefort

Baby-Dump België BE 0508.619.993 · Mechelen

VAN HULLE JEAN - PIERRE BE 0438.607.472 · Stekene

BRICO RULOT BE 0438.420.501 · Tinlot